Specifically, Spearman correlations between miR-validated miRNAs and clinical features relevant to AD diagnosis (Aβ42, total h-tau, and P-tau181) in prodromal AD and AD patients were analyzed. This evidence concerns the gene MAPT and Alzheimer disease.